Short answer · Medically reviewed summary · Last updated: 2026-04-07
TL;DR: Microphthalmia is a rare ocular condition characterized by one or both eyes being abnormally small, with an estimated global prevalence of approximately 1 in 7,000 to 1 in 10,000 live births. While it is classified as a rare disease, the exact prevalence is often difficult to determine due to variations in clinical diagnostic criteria and the frequent co-occurrence of other developmental anomalies. What is the estimated prevalence and incidence of Microphthalmia? Microphthalmia is considered a rare developmental disorder.
TL;DR: Microphthalmia is a rare ocular condition characterized by one or both eyes being abnormally small, with an estimated global prevalence of approximately 1 in 7,000 to 1 in 10,000 live births. While it is classified as a rare disease, the exact prevalence is often difficult to determine due to variations in clinical diagnostic criteria and the frequent co-occurrence of other developmental anomalies.
Microphthalmia is considered a rare developmental disorder. According to data from Orphanet, the birth prevalence of Microphthalmia—often grouped with anophthalmia (the complete absence of eye tissue)—is estimated to be between 1 and 3 per 10,000 live births globally. Because the condition is often part of a broader syndrome or chromosomal anomaly, the incidence can vary significantly by population. While many cases are sporadic, the rarity of the condition means that population-based registries are essential for tracking new cases, though they often struggle to capture the full spectrum of severity, from mild cases to total anophthalmia.
Research suggests that Microphthalmia does not show a statistically significant predilection for one gender over the other, affecting males and females with relatively equal frequency. The condition is primarily pediatric, as it is a congenital developmental disorder present at birth. Regarding geographic or ethnic variations, there is no definitive evidence suggesting that Microphthalmia is more prevalent in specific ethnic groups; however, variations in reporting standards across international health systems often lead to discrepancies in recorded data.
Accurately mapping the prevalence of Microphthalmia is complicated by several factors that lead to underdiagnosis or misclassification. Challenges include:
At DiseaseMaps.org, we currently have 3 community members who have shared their lived experience with Microphthalmia. While this is a small sample, it highlights the unique, often isolating nature of living with a rare ocular condition. Connecting with others through platforms like DiseaseMaps.org provides a necessary bridge between clinical statistics and the real-world experiences of families navigating the challenges of Microphthalmia, from early intervention therapies to long-term vision management.
Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.